Severe sepsis criteria, PELOD-2, and pSOFA as predictors of mortality in critically ill children with sepsis

  • Anindita Wulandari PPDS FK UNS
  • Pudjiastuti Pudjiastuti
  • Sri Martuti
Keywords: children, mortality, sepsis, PELOD-2, SIRS, SOFA


Background Sepsis is one of the main causes of death in infants and children. Currently, it is defined as a life-threatening organ dysfunction, caused by an inflammatory response of infection. Several organ dysfunction assessment methods are available, but they are not uniformly used.

Objective To compare the accuracy of three mortality predictor tools: severe sepsis criteria, pediatric logistic organ dysfunction (PELOD)-2, and pediatric sequential organ failure assessment (pSOFA), in critically ill children with sepsis.

Methods This prospective cohort study was conducted in the pediatric intensive care unit (PICU) and pediatric high care unit (HCU) of dr. Moewardi Hospital, Surakarta, Central of Java. All patients who met the systemic inflammatory response syndrome (SIRS) criteria were included in our study. The exclusion criteria were congenital anomalies of heart or kidney, malignancy, or hematological abnormalities. The data were taken from laboratory and physical examinations by the physicians on duty. The outcome assessed was mortality.

Results Of 30 subjects, the mean age was 22.22 (SD 29.36) months; the most common infection source was the respiratory tract, followed by gastrointestinal tract and central nervous system. Most subjects were treated in the PICU and had a mean length of stay of 8.70 (SD 11.91) days. Severe sepsis and PELOD-2 were not significant predictors of death. However, pSOFA score was a statistically significant predictor of mortality, with odds ratio 10.11 (95%CI 1.054 to 97.002; P=0.039).

Conclusion Pediatric SOFA (pSOFA) is a better predictor of mortality compared to PELOD-2 and SIRS-severe sepsis. A pSOFA score ≥ 2 increases the risk of mortality by 10.11-fold.


1. Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-bustamante JC, Salloo A, et al. Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 2015;191:1147–57.
2. Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis. Pediatr Crit Care Med 2013;14:686–93.
3. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis. Lancet 2015;385:430–40.
4. Schlapbach LJ, Straney L, Alexander J, MacLaren G, Festa M, Schibler A, et al. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: A multicentre retrospective cohort study. Lancet Infect Dis 2015;15:46–54.
5. Kawasaki T. Update on pediatric sepsis?: a review. J Intensive Care 2017;5:1–12.
6. Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2017;315:801–10.
7. Plunkett A, Tong J. Sepsis in children. BMJ 2015;7350:3017.
8. Hadinegoro SRS, Chairulfatah A, Latief A, Pudjiadi AH, Karyanti M, Setiabudi D, et al. Diagnosis dan tata laksana sepsis pada anak. Jakarta: Badan Penerbit IDAI; 2016.
9. Goldstein B, Giroir B, Randolph A. International Pediatric Sepsis Consensus Conference: Definitions for sepsis and organ dysfunction in pediatrics*. Pediatr Crit Care Med 2005;6:2–8.
10.Matics TJ, Sanchez-Pinto LN. Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the Sepsis-3 definitions in critically ill children. JAMA Pediatr 2017;60611:1-9.
11.Saraswati DD, Pudjiadi AH, Djer MM, Supriyatno B, Syarif DR, Kurniati N. Faktor risiko yang berperan pada mortalitas sepsis. Sari Pediatr 2014;15:281–8.
12.Rusmawatiningtyas D, Nurnaningsih N. Mortality rates in pediatric septic shock. Paediatr Indones 2017;56:304.
13.Mathias B, Mira JC, Larson SD. Pediatric sepsis. Wolters Kluwer Heal. 2016;28:1–8.
14.Everard ML. Paediatric respiratory infections. Eur Respir Rev 2016;25:36–40.
15.Leteurtre S, Duhamel A, Salleron J, Grandbastien B, Lacroix J, Leclerc F. PELOD-2: An update of the pediatric logistic organ dysfunction score. Crit Care Med 2013;41:1761–73.
16.Scott HF, Deakyne SJ, Woods JM, Bajaj L. The prevalence and diagnostic utility of systemic inflammatory response syndrome vital signs in a pediatric emergency department. Acad Emerg Med 2015;22:382–9.
17.Agyeman PKA, Schlapbach LJ, Giannoni E, Stocker M, Posfay-Barbe KM, Heininger U, et al. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. Lancet Child Adolesc Heal 2017;1:124–33.
18.Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA - J Am Med Assoc 2017;317:290–300.
19.Schlapbach LJ, Straney L, Bellomo R, Maclaren G, Pilcher D. Prognostic accuracy of age ? adapted SOFA, SIRS, PELOD ? 2, and qSOFA for in?hospital mortality among children with suspected infection admitted to the intensive care unit. Intensive Care Med 2018;44:179–88.
20.Leteurtre S, Leclerc F, Duhamel A, Deken V, Grandbastien B, Biarent D, et al. Groupe Francophone de Reanimation et Urgences Pediatrques (GFRUP). Can the pediatric logistic organ dysfunction (PELOD)-2 score on day 1 be used in clinical criteria for sepsis in children? Pediatr Crit Care Med 2017;18:758–63.
21.Bramantyo TB, Martuti S, Salimo H. Perbandingan prediktor mortalitas skor PRISM III dan PELOD 2 pada anak sakit kritis non bedah. Sari Pediatr 2018;19:284.
How to Cite
Wulandari A, Pudjiastuti P, Martuti S. Severe sepsis criteria, PELOD-2, and pSOFA as predictors of mortality in critically ill children with sepsis. PI [Internet]. 6Dec.2019 [cited 3Oct.2023];59(6):318-4. Available from:
Emergency & Pediatric Intensive Care
Received 2019-07-11
Accepted 2019-12-06
Published 2019-12-06